Indian pharmaceutical industry leaders indicate that proposed US tariffs on pharmaceutical exports may lead to increased drug costs and potential shortages in the US. They argue that the tariffs might be absorbed by consumers and stress the significant cost savings that affordable Indian generics provide to the US healthcare system.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/XkgjyJr
via IFTTT
No comments:
Post a Comment